3737 — Zhongzhi Pharmaceutical Holdings Share Price
0.000.00%
Last trade - 00:00- HK$794.51m
- HK$822.74m
- CNY2.21bn
- 72
- 89
- 29
- 72
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.67 | ||
| Price to Tang. Book | 0.68 | ||
| Price to Free Cashflow | 18.84 | ||
| Price to Sales | 0.34 | ||
| EV to EBITDA | 2.92 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 12.26% | ||
| Return on Equity | 8.8% | ||
| Operating Margin | 6.95% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 1,603.88 | 1,746.5 | 1,825.93 | 2,049.81 | 2,214.78 | n/a | n/a | 10.54% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +21.28 | -62.69 | +100.92 | +53.51 | -41.5 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Zhongzhi Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceutical products. The Company's products mainly comprise Chinese patent medicines and decoction pieces, mainly consisting of traditional decoction pieces and modern decoction pieces. The Company operates through two segments, including Pharmaceutical Manufacturing segment and Operation of Chain Pharmacies segment. The Company owns brands such as Zhongzhi and Cao Jinghua. The Company's product series also comprises PoBiCaoBen and ZhongChengYao. The Company mainly conducts its businesses in the domestic market.
Directors
- Tian Lai CHM (50)
- Ying Feng Lai CEO (29)
- Ying Sheng Lai CFO (27)
- Jiong Chen GMG (42)
- Mei Fang Jiang GMG (54)
- Wu Yi Li GMG (44)
- Jun Cao DGM (50)
- Jin Le Cheng EDR (55)
- Lin Tang OTH (52)
- Wing Yan Ho SEC
- Jiang Li Xia Lai NED (52)
- Zhiyun Peng NED (52)
- Kwun Wan Ng NID (52)
- Kam Wah Wong NID (47)
- Dai Han Zhou NID (75)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 12th, 2014
- Public Since
- July 13th, 2015
- No. of Employees
- 2,577
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 863,600,000
- Address
- No.3 Kangtai Road South, ZHONGSHAN
- Web
- https://www.zeus.cn/
- Phone
- +86 76085331222
- Auditors
- Ernst & Young
Upcoming Events for 3737
Zhongzhi Pharmaceutical Holdings Ltd Annual Shareholders Meeting
Dividend For 3737.HK - 0.0500 HKD
Similar to 3737
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Zhongzhi Pharmaceutical Holdings share price?
As of Today at 24:16 UTC, shares in Zhongzhi Pharmaceutical Holdings are trading at HK$0.92. This share price information is delayed by 15 minutes.
How has the Zhongzhi Pharmaceutical Holdings share price performed this year?
Shares in Zhongzhi Pharmaceutical Holdings last closed at HK$0.92 and the price had moved by -24.59% over the past 365 days. In terms of relative price strength the Zhongzhi Pharmaceutical Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -23.73% over the past year.
What are the analyst and broker recommendations for Zhongzhi Pharmaceutical Holdings?
There is no consensus recommendation for this security.
Find out moreWhat is the Zhongzhi Pharmaceutical Holdings dividend yield?
The Zhongzhi Pharmaceutical Holdings dividend yield is 5.44% based on the trailing twelve month period.
Does Zhongzhi Pharmaceutical Holdings pay a dividend?
Last year, Zhongzhi Pharmaceutical Holdings paid a total dividend of CNY0.05, and it currently has a trailing dividend yield of 5.44%.Looking ahead, shares in Zhongzhi Pharmaceutical Holdings are due to go ex-dividend on 2025-05-23 and the next dividend pay date is 2025-06-19.
When does Zhongzhi Pharmaceutical Holdings next pay dividends?
Zhongzhi Pharmaceutical Holdings are due to go ex-dividend on 2025-05-23 and the next dividend pay date is 2025-06-19. The historic dividend yield on Zhongzhi Pharmaceutical Holdings shares is currently 5.44%.
How do I buy Zhongzhi Pharmaceutical Holdings shares?
To buy shares in Zhongzhi Pharmaceutical Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Zhongzhi Pharmaceutical Holdings?
As of the previous close price of HK$0.92, shares in Zhongzhi Pharmaceutical Holdings had a market capitalisation of HK$794.51m.
Where are Zhongzhi Pharmaceutical Holdings shares listed?
Here are the trading details for Zhongzhi Pharmaceutical Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 3737
What kind of share is Zhongzhi Pharmaceutical Holdings?
Based on an overall assessment of its quality, value and momentum Zhongzhi Pharmaceutical Holdings is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Zhongzhi Pharmaceutical Holdings share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Zhongzhi Pharmaceutical Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zhongzhi Pharmaceutical Holdings. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +4.82%.
As of the last closing price of HK$0.92, shares in Zhongzhi Pharmaceutical Holdings were trading -5.76% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Zhongzhi Pharmaceutical Holdings PE Ratio?
The Zhongzhi Pharmaceutical Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.92.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Zhongzhi Pharmaceutical Holdings?
Zhongzhi Pharmaceutical Holdings' management team is headed by:
- Tian Lai - CHM
- Ying Feng Lai - CEO
- Ying Sheng Lai - CFO
- Jiong Chen - GMG
- Mei Fang Jiang - GMG
- Wu Yi Li - GMG
- Jun Cao - DGM
- Jin Le Cheng - EDR
- Lin Tang - OTH
- Wing Yan Ho - SEC
- Jiang Li Xia Lai - NED
- Zhiyun Peng - NED
- Kwun Wan Ng - NID
- Kam Wah Wong - NID
- Dai Han Zhou - NID